Searched for: +
(1 - 3 of 3)
document
Stelloo, Suzan (author), Nevedomskaya, Ekaterina (author), Kim, Yongsoo (author), Schuurman, Karianne (author), Valle-Encinas, Eider (author), Lobo, João (author), Krijgsman, Oscar (author), Peeper, Daniel Simon (author), Chang, Seiwon Laura (author), Wessels, L.F.A. (author)
The Androgen Receptor (AR) is the key-driving transcription factor in prostate cancer, tightly controlled by epigenetic regulation. To date, most epigenetic profiling has been performed in cell lines or limited tissue samples. Here, to comprehensively study the epigenetic landscape, we perform RNA-seq with ChIP-seq for AR and histone...
journal article 2018
document
Gallenne, Tristan (author), Ross, Kenneth N. (author), Visser, Nils L. (author), Desmet, Christian J. (author), Wittner, Ben S. (author), Wessels, L.F.A. (author), Ramaswamy, Sridhar (author), Peeper, Daniel Ss (author)
Prognostic classifiers conceivably comprise biomarker genes that functionally contribute to the oncogenic and metastatic properties of cancer, but this has not been investigated systematically. The transcription factor Fra-1 not only has an essential role in breast cancer, but also drives the expression of a highly prognostic gene set. Here,...
journal article 2017
document
Schouten, P.C. (author), Grigoriadis, A. (author), Kuilman, T. (author), Mirza, H. (author), Watkins, J.A. (author), Cooke, S.A. (author), Van Dyk, E. (author), Severson, T.M. (author), Rueda, O.M. (author), Hoogstraat, M. (author), Verhagen, C. (author), Natrajan, R. (author), Chin, S.F. (author), Lips, E.H. (author), Kruizinga, J. (author), Velds, A. (author), Nieuwland, M. (author), Kerkhoven, R.M. (author), Krijgsman, O. (author), Vens, C. (author), Peeper, D. (author), Nederlof, P.M. (author), Caldas, C. (author), Tutt, A.N. (author), Wessels, L.F.A. (author), Linn, S.C. (author)
Breast cancers with BRCA1 germline mutation have a characteristic DNA copy number (CN) pattern. We developed a test that assigns CN profiles to be ‘BRCA1-like’ or ‘non-BRCA1-like’, which refers to resembling a BRCA1-mutated tumor or resembling a tumor without a BRCA1 mutation, respectively. Approximately one third of the BRCA1-like breast...
journal article 2015